http://www.catalystpharma.com
Catalyst Pharmaceuticals, Inc. Company Intro
Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.
Industry
Healthcare
Catalyst Pharmaceuticals, Inc. Headquaters
355 Alhambra Circle
Coral Gables,33134
United States
Catalyst Pharmaceuticals, Inc. Share price
16 Apr 2021 01:26 GMT
$4.5000
0.04 (0.9 %)
Catalyst Pharmaceuticals, Inc. Market cap
$464.098 M
WMC RANKING
2021
Catalyst Pharmaceuticals, Inc. # 55
BiotechnologyLatest Catalyst Pharmaceuticals, Inc. News
16 Apr 2021
What Caused Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX ...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) concluded the trading at $4.47 on Thursday, Apr 15,, with a rise of 0.22% from its closing price on previous day.
16 Apr 2021
Daily High to Daily Low: Is It Safe to Buy Catalyst ...
Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) went up by 0.22% from its latest closing price compared to the recent 1-year high of $5.19. The company's stock ...
16 Apr 2021
The 5 Best Biotech Stocks Under $20
Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) is another profitable biotech. It focuses on therapeutics for rare neurological diseases. Its balance sheet is clean ...
WMC Market Score
WMC Market to Revenue Score
Catalyst Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Catalyst Pharmaceuticals, Inc. | USD | $118,180 | $60,921 | $71,476 | $4,641M | 55 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $529,920B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $572,250B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $348,030B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $182,910B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Catalyst Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Catalyst Pharmaceuticals, Inc. | 1.28 | 2.09 | 0.24 | 0 | 0 | 0 | 0.89 |
| Regeneron Pharmaceuticals, Inc. | 100 | 23.96 | 10.26 | 100 | 0 | 0 | 51.60 |
| Vertex Pharmaceuticals Incorporated | 67.14 | 35.08 | 2.77 | 86 | 0 | 0 | 47.55 |
| Alexion Pharmaceuticals, Inc. | 65.67 | 100 | 100 | 60 | 0 | 0 | 100 |
| Incyte Corporation | 24.12 | 4.95 | 0.25 | 2 | 0 | 0 | 2.93 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
